Emotional repression in patients with chronic inflammatory rheumatism
Background: A person’s psychological background may support and direct the inflammatory evolution of a disease toward a specific type of chronic inflammatory rheumatism (CIR).
Aim: This study aimed to identify a particular emotional profile of patients with CIR, particularly rheumatoid arthritis (RA) and spondyloarthritis (SpA), based on psychological profile assessments between patients with and without CIR. Emotional repression, that is, a tendency to inhibit the expression of negative feelings and/or unpleasant thoughts, was particularly studied.
Methods: This monocentric observational pilot study included patients from the rheumatology department of a university hospital. These patients were systematically assessed for different psychological parameters by an experienced psychiatrist, and their clinical and biological characteristics were collected accordingly. Data analysis was performed using the Chi-squared test or Fisher’s exact test.
Results: Fifty-nine patients were assessed: 47 patients with CIR (i.e., 27 with RA and 20 with SpA) (CIR group) and 12 non-CIR patients (i.e., nine with osteoarthritis, one with viral disease, one with osteoporosis, and one with osteomalacia) (control group). Severe emotional repression and early life events were both significantly higher in the CIR group than in the control group (P = 0.02). In contrast, severe psychological and somatic complaints were significantly higher in the control group than in the CIR group (P < 0.01 and P = 0.01, respectively).
Conclusion: Our findings suggested that emotional repression from traumatic life events could aggravate the etiology and/or course of CIR. Therefore, appropriate psychological care should have a relevant place within the current therapeutic options for the clinical management of CIR.
Relevance for Patients: The management of CIR should include psychological support as learning coping mechanisms can facilitate the recovery of CIR patients.
[1] Pretorius E, Akeredolu OO, Soma P, Kell DB. Major Involvement of Bacterial Components in Rheumatoid Arthritis and Its Accompanying Oxidative Stress, Systemic Inflammation and Hypercoagulability. Exp Biol Med (Maywood) 2017;242:355-73. doi: 10.1177/1535370216681549
[2] Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:212737. doi: 10.1016/S0140-6736(11)60071-8
[3] Halliday JL. Psychological Aspects of Rheumatoid Arthritis. Proc R Soc Med 1942;35:4557.
[4] Moos RH. Personality Factors Associated with Rheumatoid Arthritis: A review. J Chronic Dis 1964;17:4155. doi: 10.1016/0021-9681(64)90038-4
[5] Söderlin MK, Bergsten U, Svensson B, BARFOT Study Group. Patient-Reported Events Preceding the Onset of Rheumatoid Arthritis: Possible Clues to Aetiology. Musculoskeletal Care 2011;9:2531. doi: 10.1002/msc.193
[6] Montgomery SA, Asberg M. A New Depression Scale Designed to be Sensitive to Change. Br J Psychiatry 1979;134:3829. doi: 10.1192/bjp.134.4.382
[7] Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An Inventory for Measuring Depression. Arch Gen Psychiatry 1961;4:56171. doi: 10.1001/archpsyc.1961.01710120031004
[8] Sifneos PE. Alexithymia: Past and present. Am J Psychiatry 1996;153:13742. doi: 10.1176/ajp.153.7.137
[9] Sifneos PE. The Prevalence of ‘alexithymic’Characteristics in Psychosomatic Patients. Psychother Psychosom 1973;22:25562. doi: 10.1159/000286529
[10] Bagby RM, Taylor GJ, Parker JD. Construct Validity of the Toronto Alexithymia Scale. Psychother Psychosom 1988;50:2934. doi: 10.1159/000288097
[11] Crowne DP, Marlowe D. ANew Scale of Social Desirability Independent of Psychopathology. J Consult Psychol 1960;349-354. doi: 10.1037/h0047358
[12] Gaudry E, Vagg P, Spielberger CD. Validation of the StateTrait Distinction in Anxiety Research. Multivar Behav Res 1975;10:33141. doi: 10.1207/s15327906mbr1003_6
[13] Temoshok L. Personality, Coping Style, Emotion and cancer: Towards an Integrative Model. Cancer Surv 1987;6:54567.
[14] Grossarth-Maticek R, Vetter H, Frentzel-Beyme R, Heller WD. Precursor Lesions of the GI Tract and Psychosocial Risk Factors for Prediction and Prevention of Gastric Cancer. Cancer Detect Prev 1988;13:239.
[15] Grossarth-Maticek R, Eysenck HJ, Boyle GJ, Heep J, Costa SD, Diel IJ, et al. Interaction of Psychosocial and Physical Risk Factors in the Causation of Mammary Cancer, and Its Prevention through Psychological Methods of Treatment. J Clin Psychol 2000;56:3350. doi: 10.1002/(sici)1097-4679(200001)56:1<33::aidjclp4>3.0.co;2-2
[16] Bayle O, Consoli SM, Baudin M, Vayssairat M, Fiessinger JN, Housset E. Idiopathic and Secondary Raynaud’s Phenomenon. A Comparative Psychosomatic Approach. Presse Med 1990;19:7415.
[17] Nagano J, Morita T, Taneichi K, Nagaoka S, Katsube S, Asai T, et al. Rational/Antiemotional Behaviors in Interpersonal Relationships and the Functional Prognosis of Patients with Rheumatoid Arthritis: AJapanese Multicenter, Longitudinal Study. Biopsychosoc Med 2014;8:8.doi: 10.1186/1751-0759-8-8
[18] Ishii H, Nagashima M, Tanno M, Nakajima A, Yoshino S. Does Being Easily Moved to Tears as a Response to Psychological Stress Reflect Response to Treatment and the General Prognosis in Patients with Rheumatoid Arthritis? Clin Exp Rheumatol 2003;21:6116.
[19] Butow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC. Epidemiological Evidence for a Relationship Between Life Events, Coping Style, and Personality Factors in the Development of Breast Cancer. J Psychosom Res 2000;49:16981. doi: 10.1016/s0022-3999(00)00156-2
[20] Zachariae R, Jensen AB, Pedersen C, Jørgensen MM, Christensen S, Lassesen B, et al. Repressive Coping Before and After Diagnosis of Breast Cancer. Psychooncology 2004;13:54761. doi: 10.1002/pon.772.
[21] Cutolo M, Straub RH. Stress as a Risk Factor in the Pathogenesis of Rheumatoid Arthritis. Neuroimmunomodulation 2006;13:27782 doi: 10.1159/000104855
[22] Straub RH, Cutolo M. Does Stress Influence the Course of Rheumatic Diseases? Clin Exp Rheumatol 2006;24:2258.
[23] Rimón R, Laakso RL. Life Stress and Rheumatoid Arthritis. A 15-Year Follow-Up Study. Psychother Psychosom 1985;43:3843. doi: 10.1159/000287856.
[24] O’Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K, et al. Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder. Biol Psychiatry 2015;77:36574. doi: 10.1016/j.biopsych.2014.06.015
[25] Boscarino JA, Forsberg CW, Goldberg J. A Twin Study of the Association between PTSD Symptoms and Rheumatoid Arthritis. Psychosom Med 2010;72:4816 doi: 10.1097/PSY.0b013e3181d9a80c
[26] Webster Marketon JI, Glaser R. Stress Hormones and Immune Function. Cell Immunol 2008;252(1-2):1626. doi: 10.1016/j.cellimm.2007.09.006
[27] Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to endotoxin. Nature 2000;405:45862. doi: 10.1038/35013070
[28] Levite M. Neuropeptides, by Direct Interaction with T Cells, Induce Cytokine Secretion and Break the Commitment to a Distinct T Helper Phenotype. Proc Natl Acad Sci U S A 1998;95:125449. doi: 10.1073/pnas.95.21.12544
[29] Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association Between Plasma IL-6 Response to Acute Stress and Early-Life Adversity in Healthy Adults. Neuropsychopharmacol 2010;35:261723. doi: 10.1038/npp.2010.159
[30] Janusek LW, Tell D, Gaylord-Harden N, Mathews HL. Relationship of Childhood Adversity and Neighborhood Violence to a Proinflammatory Phenotype in Emerging adult African American men: An Epigenetic Link. Brain Behav Immun 2017;60:12635. doi: 10.1016/j.bbi.2016.10.006
[31] Reynier-Legarçon E, Clément JP, Calvet B, Bézananary H, Liozon E, Gondran G, et al. Personnalité et Maladies AutoImmunes Systémiques. Rev Méd Internet 2016;37:38. doi: 10.1016/j.revmed.2016.04.238
[32] Baerwald C, Manger B, Hueber A. Depression as Comorbidity of Rheumatoid arthritis. Z Rheumatol 2019;78:2438. doi: 10.1007/s00393-018-0568-5
[33] Kang W. Global and Dimensions of Mental Health in Arthritis Patients. Healthcare (Basel) 2023;11:195. doi: 10.3390/healthcare11020195
[34] Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification Criteria for Psoriatic Arthritis: Development of New Criteria from a Large International Study. Arthritis Rheum 2006;54:266573. doi: 10.1002/art.21972
[35] Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The Health-Related Quality of life in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: A Comparison with a Selected Sample of Healthy People. Health Qual Life Outcomes 2009;7:25. doi: 10.1186/1477-7525-7-25
[36] Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK. Health Status of Patients with Ankylosing Spondylitis: A Comparison with the General Population. Ann Rheum Dis 2004;63:160510. doi: 10.1136/ard.2003.019224
[37] Hyphantis T, Kotsis K, Tsifetaki N, Creed F, Drosos AA, Carvalho AF, et al. The Relationship Between Depressive Symptoms, Illness Perceptions and Quality of Life in Ankylosing Spondylitis in Comparison to Rheumatoid Arthritis. Clin Rheumatol 2013;32:63544. doi: 10.1007/s10067-012-2162-6
[38] Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do Depression and Anxiety Reduce the Likelihood of Remission in Rheumatoid Arthritis and Psoriatic Arthritis? Data from the Prospective Multicentre NOR-DMARD Study. Ann Rheum Dis 2017;76:190610. doi: 10.1136/annrheumdis-2017-211284
[39] Bijsterbosch J, Scharloo M, Visser AW, Watt I, MeulenbeltI, Huizinga TW, et al. Illness Perceptions in Patients with Osteoarthritis: Change Over Time and Association with Disability. Arthritis Rheum 2009;61:105461. doi: 10.1002/art.24674
[40] Smoak KA, Cidlowski JA. Mechanisms of Glucocorticoid Receptor Signaling During Inflammation. Mech Ageing Dev 2004;125:697706. doi: 10.1016/j.mad.2004.06.010
[41] Howren MB, Lamkin DM, Suls J. Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis. Psychosom Med 2009;71:17186. doi: 10.1097/PSY.0b013e3181907c1b
[42] Goldsmith DR, Rapaport MH, Miller BJ. A Meta-Analysis of Blood Cytokine Network Alterations in Psychiatric Patients: Comparisons between Schizophrenia, Bipolar Disorder and Depression. Mol Psychiatry 2016;21:1696709. doi: 10.1038/mp.2016.3
[43] Gobin V, Van Steendam K, Denys D, Deforce D. Selective Serotonin Reuptake Inhibitors as a Novel Class of Immunosuppressants. Int Immunopharmacol 2014;20:14856. doi: 10.1016/j.intimp.2014.02.030
[44] Minnema LA, Giezen TJ, Souverein PC, Egberts TC, Leufkens HG, Gardarsdottir H. Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A vigibase study. Drug Saf 2019;42:887-95. doi: 10.1007/s40264-018-00789-9
[45] Lebwohl MG, Papp KA, Marangell LB, Koo J, Blauvelt A, Gooderham M, et al. Psychiatric Adverse Events During Treatment with Brodalumab: Analysis of Psoriasis Clinical Trials. J Am Acad Dermatol 2018;78:81-9.e5. doi: 10.1016/j.jaad.2017.08.024